SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection
The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection.
Read Original Article: SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection »
